May 13, 2021
Cytel’s HEOR and RWE Expertise has grown quite significantly in the past year. Could you speak a little bit about the..
May 5, 2021
Cytel’s team of HEOR and RWE experts are all set to make a splash at the Virtual ISPOR on May 17 - 20. Our global..
April 29, 2021
After twenty years in pharma, Anna Forsythe was frustrated by traditional vendors who used outdated methods to prepare..
November 24, 2020
Virtual ISPOR 2020, held November 16 to 19, presented new opportunities for scientific interaction amongst HEOR..
November 5, 2020
In oncology, many manufacturers go into niche indications, where there are very specific tumors, and then they opt for..
October 22, 2020
In this two-part blog series, we interview Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel..
October 20, 2020
In this interview with Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), we talk to him about his..
October 14, 2020
A credible evidence base is needed to support and document the economic value of new technologies and therapeutic..
October 13, 2020
The combination of greater access to electronic health records, bigger electronic claims datasets, and the need for..